利用移动健康可穿戴设备管理阿尔茨海默病患者：范围审查

IF 6.5 2区医学 Q1 PHARMACOLOGY & PHARMACY

Drug Discovery Today Pub Date : 2025-05-01 DOI:10.1016/j.drudis.2025.104363

Kenta Noda , Itsuki Kageyama , Yoshiyuki Kobayashi , Yeongjoo Lim , Shintaro Sengoku , Kota Kodama

{"title":"利用移动健康可穿戴设备管理阿尔茨海默病患者：范围审查","authors":"Kenta Noda , Itsuki Kageyama , Yoshiyuki Kobayashi , Yeongjoo Lim , Shintaro Sengoku , Kota Kodama","doi":"10.1016/j.drudis.2025.104363","DOIUrl":null,"url":null,"abstract":"<div><div>In this scoping review, we examine the role of wearable devices in diagnosing, treating, and monitoring Alzheimer’s disease (AD) and mild cognitive impairment (MCI). It identifies various devices, including fitness trackers, smartwatches, electroencephalographic equipment, and sensors, which are used for monitoring physical activity, sleep patterns, and cognitive functions. Our review highlights the potential of these devices for early diagnosis and treatment, improving patient autonomy and quality of life. However, challenges, such as data privacy, device adherence, and technical limitations, remain. Future research should focus on integrating wearable devices with advanced diagnostic tools and validating their effectiveness across diverse populations.</div></div>","PeriodicalId":301,"journal":{"name":"Drug Discovery Today","volume":"30 5","pages":"Article 104363"},"PeriodicalIF":6.5000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Leveraging mHealth wearables for managing patients with Alzheimer’s disease: a scoping review\",\"authors\":\"Kenta Noda , Itsuki Kageyama , Yoshiyuki Kobayashi , Yeongjoo Lim , Shintaro Sengoku , Kota Kodama\",\"doi\":\"10.1016/j.drudis.2025.104363\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In this scoping review, we examine the role of wearable devices in diagnosing, treating, and monitoring Alzheimer’s disease (AD) and mild cognitive impairment (MCI). It identifies various devices, including fitness trackers, smartwatches, electroencephalographic equipment, and sensors, which are used for monitoring physical activity, sleep patterns, and cognitive functions. Our review highlights the potential of these devices for early diagnosis and treatment, improving patient autonomy and quality of life. However, challenges, such as data privacy, device adherence, and technical limitations, remain. Future research should focus on integrating wearable devices with advanced diagnostic tools and validating their effectiveness across diverse populations.</div></div>\",\"PeriodicalId\":301,\"journal\":{\"name\":\"Drug Discovery Today\",\"volume\":\"30 5\",\"pages\":\"Article 104363\"},\"PeriodicalIF\":6.5000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Discovery Today\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1359644625000765\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359644625000765","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 0

摘要

在这篇综述中，我们研究了可穿戴设备在阿尔茨海默病（AD）和轻度认知障碍（MCI）的诊断、治疗和监测中的作用。它可以识别各种设备，包括健身追踪器、智能手表、脑电图设备和传感器，这些设备用于监测身体活动、睡眠模式和认知功能。我们的综述强调了这些设备在早期诊断和治疗方面的潜力，提高了患者的自主性和生活质量。然而，数据隐私、设备依从性和技术限制等挑战仍然存在。未来的研究应侧重于将可穿戴设备与先进的诊断工具相结合，并验证其在不同人群中的有效性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Leveraging mHealth wearables for managing patients with Alzheimer’s disease: a scoping review

In this scoping review, we examine the role of wearable devices in diagnosing, treating, and monitoring Alzheimer’s disease (AD) and mild cognitive impairment (MCI). It identifies various devices, including fitness trackers, smartwatches, electroencephalographic equipment, and sensors, which are used for monitoring physical activity, sleep patterns, and cognitive functions. Our review highlights the potential of these devices for early diagnosis and treatment, improving patient autonomy and quality of life. However, challenges, such as data privacy, device adherence, and technical limitations, remain. Future research should focus on integrating wearable devices with advanced diagnostic tools and validating their effectiveness across diverse populations.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Drug Discovery Today 医学-药学

CiteScore

14.80

自引率

2.70%

发文量

293

审稿时长

6 months

期刊介绍： Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.